EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Robert Bm Landewé; Pedro M. Machado; F. line Kroon; Hans Wj Bijlsma; Gerd R. Burmester; Loreto Carmona; Bernard Combe; Massimo Galli; Laure Gossec; Annamaria Iagnocco; John D. Isaacs; Xavier Mariette; Iain McInnes; Ulf Mueller-Ladner; Peter Openshaw; Josef S. Smolen; Tanja A. Stamm; Dieter Wiek; Hendrik Schulze-Koops

doi:https://doi.org/10.1136/annrheumdis-2020-217877

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Robert Bm Landewé, Pedro M. Machado, F. line Kroon, Hans Wj Bijlsma, Gerd R. Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D. Isaacs, Xavier Mariette, Iain McInnes, Ulf Mueller-Ladner, Peter Openshaw, Josef S. Smolen, Tanja A. Stamm, Dieter Wiek, Hendrik Schulze-Koops

Research output: Contribution to journal › Article › Academic › peer-review

224 Citations (Scopus)

Abstract

The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal diseases (RMD) and their caregivers. A task force of 20 members was convened by EULAR that met several times by videoconferencing in April 2020. The task force finally agreed on five overarching principles and 13 recommendations covering four generic themes: (1) General measures and prevention of SARS-CoV-2 infection. (2) The management of RMD when local measures of social distancing are in effect. (3) The management of COVID-19 in the context of RMD. (4) The prevention of infections other than SARS-CoV-2. EULAR considers this set of recommendations as a 'living document' and a starting point, which will be updated as soon as promising new developments with potential impact on the care of patients with RMD become available.

Original language	English
Pages (from-to)	851-858
Number of pages	8
Journal	Annals of the rheumatic diseases
Volume	79
Issue number	7
DOIs	https://doi.org/10.1136/annrheumdis-2020-217877
Publication status	Published - 1 Jul 2020

Keywords

antirheumatic agents
epidemiology
health services research
patient care team
quality indicators, health care

Access to Document

https://doi.org/10.1136/annrheumdis-2020-217877

Cite this

Landewé, R. B., Machado, P. M., Kroon, F. L., Bijlsma, H. W., Burmester, G. R., Carmona, L., Combe, B., Galli, M., Gossec, L., Iagnocco, A., Isaacs, J. D., Mariette, X., McInnes, I., Mueller-Ladner, U., Openshaw, P., Smolen, J. S., Stamm, T. A., Wiek, D., & Schulze-Koops, H. (2020). EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Annals of the rheumatic diseases, 79(7), 851-858. https://doi.org/10.1136/annrheumdis-2020-217877

@article{ff0eb397450041ddb8dcd3d43f3ac031,

title = "EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2",

abstract = "The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal diseases (RMD) and their caregivers. A task force of 20 members was convened by EULAR that met several times by videoconferencing in April 2020. The task force finally agreed on five overarching principles and 13 recommendations covering four generic themes: (1) General measures and prevention of SARS-CoV-2 infection. (2) The management of RMD when local measures of social distancing are in effect. (3) The management of COVID-19 in the context of RMD. (4) The prevention of infections other than SARS-CoV-2. EULAR considers this set of recommendations as a 'living document' and a starting point, which will be updated as soon as promising new developments with potential impact on the care of patients with RMD become available.",

keywords = "antirheumatic agents, epidemiology, health services research, patient care team, quality indicators, health care",

author = "Landew{\'e}, {Robert Bm} and Machado, {Pedro M.} and Kroon, {F. line} and Bijlsma, {Hans Wj} and Burmester, {Gerd R.} and Loreto Carmona and Bernard Combe and Massimo Galli and Laure Gossec and Annamaria Iagnocco and Isaacs, {John D.} and Xavier Mariette and Iain McInnes and Ulf Mueller-Ladner and Peter Openshaw and Smolen, {Josef S.} and Stamm, {Tanja A.} and Dieter Wiek and Hendrik Schulze-Koops",

year = "2020",

month = jul,

day = "1",

doi = "https://doi.org/10.1136/annrheumdis-2020-217877",

language = "English",

volume = "79",

pages = "851--858",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "7",

}

Landewé, RB, Machado, PM, Kroon, FL, Bijlsma, HW, Burmester, GR, Carmona, L, Combe, B, Galli, M, Gossec, L, Iagnocco, A, Isaacs, JD, Mariette, X, McInnes, I, Mueller-Ladner, U, Openshaw, P, Smolen, JS, Stamm, TA, Wiek, D & Schulze-Koops, H 2020, 'EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2', Annals of the rheumatic diseases, vol. 79, no. 7, pp. 851-858. https://doi.org/10.1136/annrheumdis-2020-217877

TY - JOUR

T1 - EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

AU - Landewé, Robert Bm

AU - Machado, Pedro M.

AU - Kroon, F. line

AU - Bijlsma, Hans Wj

AU - Burmester, Gerd R.

AU - Carmona, Loreto

AU - Combe, Bernard

AU - Galli, Massimo

AU - Gossec, Laure

AU - Iagnocco, Annamaria

AU - Isaacs, John D.

AU - Mariette, Xavier

AU - McInnes, Iain

AU - Mueller-Ladner, Ulf

AU - Openshaw, Peter

AU - Smolen, Josef S.

AU - Stamm, Tanja A.

AU - Wiek, Dieter

AU - Schulze-Koops, Hendrik

PY - 2020/7/1

Y1 - 2020/7/1

N2 - The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal diseases (RMD) and their caregivers. A task force of 20 members was convened by EULAR that met several times by videoconferencing in April 2020. The task force finally agreed on five overarching principles and 13 recommendations covering four generic themes: (1) General measures and prevention of SARS-CoV-2 infection. (2) The management of RMD when local measures of social distancing are in effect. (3) The management of COVID-19 in the context of RMD. (4) The prevention of infections other than SARS-CoV-2. EULAR considers this set of recommendations as a 'living document' and a starting point, which will be updated as soon as promising new developments with potential impact on the care of patients with RMD become available.

AB - The provisional EULAR recommendations address several aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus, and the disease caused by SARS-CoV-2, COVID-19 and are meant for patients with rheumatic and musculoskeletal diseases (RMD) and their caregivers. A task force of 20 members was convened by EULAR that met several times by videoconferencing in April 2020. The task force finally agreed on five overarching principles and 13 recommendations covering four generic themes: (1) General measures and prevention of SARS-CoV-2 infection. (2) The management of RMD when local measures of social distancing are in effect. (3) The management of COVID-19 in the context of RMD. (4) The prevention of infections other than SARS-CoV-2. EULAR considers this set of recommendations as a 'living document' and a starting point, which will be updated as soon as promising new developments with potential impact on the care of patients with RMD become available.

KW - antirheumatic agents

KW - epidemiology

KW - health services research

KW - patient care team

KW - quality indicators, health care

UR - http://www.scopus.com/inward/record.url?scp=85086524921&partnerID=8YFLogxK

U2 - https://doi.org/10.1136/annrheumdis-2020-217877

DO - https://doi.org/10.1136/annrheumdis-2020-217877

M3 - Article

C2 - 32503854

SN - 0003-4967

VL - 79

SP - 851

EP - 858

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 7

ER -

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Abstract

Keywords

Access to Document

Other files and links

Cite this